Asana BioSciences Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
3
- Investments
-
1
Asana BioSciences General Information
Description
Provider of clinical-stage biological research and development services intended to serve the healthcare industry. The company operates as a biopharmaceutical firm with a service portfolio that consists of multiple early-stage drug discovery and development pipelines aimed at producing novel targeted therapies in the areas of oncology, inflammation, immunology and pain, enabling its partners to contribute to the later stages of development and commercialization of the product and to increase the potential of the product aiming to offer new treatment options to physicians and patients.
Contact Information
Website
www.asanabio.comCorporate Office
- 997 Lenox Drive, Suite 220
- Princeton Pike Corporate Center
- Lawrenceville, NJ 08648
- United States
Corporate Office
- 997 Lenox Drive, Suite 220
- Princeton Pike Corporate Center
- Lawrenceville, NJ 08648
- United States
Asana BioSciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Asana BioSciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Asana BioSciences Patents
Asana BioSciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240082417-A1 | Protein-polymer drug conjugates | Inactive | 14-Jul-2022 | ||
| AU-2022300355-A1 | Erk1/2 inhibitor combination therapy | Inactive | 24-Jun-2021 | ||
| CA-3223692-A1 | Erk1/2 inhibitor combination therapy | Pending | 24-Jun-2021 | ||
| EP-4358967-A1 | Erk1/2 inhibitor combination therapy | Inactive | 24-Jun-2021 | ||
| EP-4358967-A4 | Erk1/2 inhibitor combination therapy | Inactive | 24-Jun-2021 | A61K31/506 |
Asana BioSciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Asana BioSciences Acquisitions (1)
Asana BioSciences’s most recent deal was a Merger/Acquisition with Endo Pharmaceuticals Solutions. The deal was made on 02-Jun-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Endo Pharmaceuticals Solutions | 02-Jun-2014 | Merger/Acquisition | Pharmaceuticals |
Asana BioSciences FAQs
-
When was Asana BioSciences founded?
Asana BioSciences was founded in 2014.
-
Where is Asana BioSciences headquartered?
Asana BioSciences is headquartered in Lawrenceville, NJ.
-
What is the size of Asana BioSciences?
Asana BioSciences has 12 total employees.
-
What industry is Asana BioSciences in?
Asana BioSciences’s primary industry is Drug Discovery.
-
Is Asana BioSciences a private or public company?
Asana BioSciences is a Private company.
-
What is Asana BioSciences’s current revenue?
The current revenue for Asana BioSciences is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
